A Randomized Trial of Sodium Fluoride (60 mg) ± Estrogen in Postmenopausal Osteoporotic Vertebral Fractures: Increased Vertebral Fractures and Peripheral Bone Loss with Sodium Fluoride; Concurrent Estrogen Prevents Peripheral Loss, But Not Vertebral Fractures

✍ Scribed by D. H. Gutteridge; D. H. Gutteridge; G. O. Stewart; R. L. Prince; R. L. Prince; R. I. Price; R. W. Retallack; S. S. Dhaliwal; B. G. A. Stuckey; P. Drury; C. E. Jones; D. L. Faulkner; G. N. Kent; C. I. Bhagat; G. C. Nicholson*; G. C. Nicholson*; K. Jamrozik†

• Publisher: Springer-Verlag
• Year: 2002
• Tongue: English
• Weight: 214 KB
• Volume: 13
• Category: Article
• ISSN: 0937-941X
• DOI: 10.1007/s001980200008